Reuters logo
BRIEF-Novozymes ‍Q2 EBIT at DKK ‍​963 mln, below expectations
August 11, 2017 / 6:11 AM / a month ago

BRIEF-Novozymes ‍Q2 EBIT at DKK ‍​963 mln, below expectations

Aug 11 (Reuters) - NOVOZYMES:

* ‍Q2 EBIT MARGIN AT 28.2%, EXCLUDING REORGANIZATION COSTS (Q2 2016: 28.0%)​

* Q2 EBIT DKK ‍​963 MILLION (REUTERS POLL DKK 994 MILLION)

* Q2 NET PROFIT 735 MILLION (REUTERS POLL DKK 764 MILLION)

* Q2 SALES DKK 3.54 BILLION (REUTERS POLL DKK 3.58 BILLION)

* MAINTAINS ITS FULL-YEAR ORGANIC SALES GROWTH OUTLOOK OF 2-5%‍​

* CONTINUES TO EXPECT HIGHER H2 Y/Y ORGANIC GROWTH RELATIVE TO THE 3% DELIVERED IN H1 Y/Y

* UNDERLYING EBIT GROWTH OUTLOOK FOR THE FULL YEAR IS MAINTAINED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below